Marinomed Biotech AG 2025 SR
The report outlines Marinomed's sustainability performance and strategies for the 2025 fiscal year across environmental, social, and governance (ESG) dimensions. Key highlights include achieving 100% renewable energy in electricity consumption, with 14% generated by the company's own photovoltaic system. Marinomed also maintained high gender diversity, with women representing 68% of the total workforce and 50% of the Management Board. Additionally, the company continued to advance its sustainable Marinosolv technology to improve drug solubility and reduce environmental impact.
Company: Marinomed Biotech AG
Sector: Health Care
Country: Austria
Year: 2025
Type: SR
Pages: 34
Marinomed Biotech AG
Sustainability Report
The report outlines Marinomed's sustainability performance and strategies for the 2025 fiscal year across environmental, social, and governance (ESG) dimensions. Key highlights include achieving 100% renewable energy in electricity consumption, with 14% generated by the company's own photovoltaic system. Marinomed also maintained high gender diversity, with women representing 68% of the total workforce and 50% of the Management Board. Additionally, the company continued to advance its sustainable Marinosolv technology to improve drug solubility and reduce environmental impact.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
2025
Fiscal Year
2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Women on Board
Women in Management
Net Zero Target
Employees